atorvastatin has been researched along with Carotid Artery Narrowing in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 17 (48.57) | 29.6817 |
| 2010's | 15 (42.86) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF | 1 |
| Mikhailidis, DP; Paraskevas, KI | 1 |
| Aurigemma, C; D'Ambrosio, A; Di Sciascio, G; Giardina, A; Leporace, M; Macrì, M; Melfi, R; Patti, G; Ricottini, E; Sedati, P; Tomai, F | 1 |
| Bauer, I; Bertolotto, M; Dallegri, F; Fabre, M; Galan, K; Lenglet, S; Mach, F; Montecucco, F; Nencioni, A; Palombo, D; Pane, B; Pelli, G; Pende, A; Python, M; Quercioli, A; Spinella, G; Vuilleumier, N | 1 |
| Chen, T; Liang, L; Shen, Y; Yan, Y; Yuan, Y; Zhong, C | 1 |
| Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Sillesen, H; Welch, KM; Zivin, J | 1 |
| Blanco-Colio, LM; Egido, J; Madrigal-Matute, J; Martín-Conejero, A; Martín-Ventura, JL; Muñoz-Garcia, B; Ortega, L; Serrano, J; Vega, M | 1 |
| Briley-Saebo, KC; Fayad, ZA; Mani, V; Razzouk, L | 1 |
| Boyle, JR; Brown, AP; Gaunt, ME; Gillard, JH; Graves, MJ; Hayes, PD; Howarth, SP; Kirkpatrick, PJ; Li, ZY; Miller, SR; Patterson, AJ; Tang, TY; U-King-Im, JM; Varty, K; Walsh, SR; Warburton, EA; Zalewski, A | 1 |
| Castilla-Guerra, L; Chaturvedi, S; Fernandez-Moreno, Mdel C; Jimenez-Hernandez, MD | 1 |
| Chiu, B; Fenster, A; Krasinski, A; Parraga, G; Spence, JD | 2 |
| Asano, T; Enomoto, Y; Iwama, T; Kawasaki, M; Minatoguchi, S; Yamada, K; Yoshimura, S | 1 |
| Gerasimidis, T; Kadoglou, NP; Kapelouzou, A; Liapis, CD; Moumtzouoglou, A; Sailer, N | 1 |
| Bahcivan, M; Erenler, BH; Gol, MK; Keceligil, HT; Kolbakir, F; Yucel, S | 1 |
| Avgerinos, ED; Gerasimidis, T; Kadoglou, NP; Kakisis, JD; Kapelouzou, A; Karayannacos, PE; Liapis, CD; Moumtzouoglou, A | 1 |
| Chen, J; Ge, S; Liu, D; Liu, X; Xu, G; Yin, Q; Zhang, R; Zhou, G; Zhu, W | 1 |
| Dermitzakis, I; Drakoulis, C; Gialernios, K; Gialernios, T; Gika, E; Iliopoulos, N; Katsadorou, E; Kougialis, S; Kroustalis, A; Mpilinis, H; Nikolaou, S; Polydorou, A; Polydorou, V; Skopelitis, E; Zervou, A | 1 |
| Gillard, JH; Jiang, F; Li, ZY; Tang, TY; Zhang, Y | 1 |
| Bramanti, P; Calabrò, RS; Gervasi, G; Pezzini, A; Pollicino, P | 1 |
| Nemati, MH | 1 |
| Broccolini, A; Della Marca, G; Di Lazzaro, V; Pilato, F; Profice, P; Santoliquido, A | 1 |
| Della-Morte, D; Elkind, MS; Moussa, I; Rundek, T; Sacco, RL | 1 |
| Spence, JD | 1 |
| Baumgartner, RW; Georgiadis, D | 1 |
| Chen, YT; Hsu, HY; Hu, HH; Sheng, WY; Sheu, WH; Wang, PY | 1 |
| Ainsworth, CD; Beletsky, V; Blake, CC; Fenster, A; Spence, JD; Tamayo, A | 1 |
| Beck, T; Burgstahler, C; Heuschmid, M; Kopp, AF; Kuettner, A; Reimann, A; Schroeder, S | 1 |
| Bray, F; Chu, B; Dodge, JT; Hatsukami, TS; Lee, CD; Moore, AB; Phan, BA; Polissar, NL; Yuan, C; Zhao, XQ | 1 |
| Chiu, B; Egger, M; Fenster, A; Parraga, G; Spence, JD | 1 |
| Abe, Y; Furukado, S; Hori, M; Hoshi, T; Hougaku, H; Kitagawa, K; Sakaguchi, M; Yamagami, H | 1 |
| Bandios, S; Fotiadis, G; Gerasimidis, T; Kadoglou, NP; Kapelouzou, A; Karayannacos, PE; Katinios, A; Kougias, P; Liapis, CD; Moumtzouoglou, A; Sailer, N; Vitta, I; Voliotis, K | 1 |
| Baetta, R; Calore, M; Comparato, C; Donetti, E; Fumagalli, R; Paoletti, R; Rossi, A; Soma, MR; Teruzzi, C | 1 |
| Ballantyne, CM; Jacobson, TA; Schein, JR; Williamson, A | 1 |
| Arbustini, E; Cofrancesco, E; Cortellaro, M; Gabrielli, L; Tremoli, E | 1 |
3 review(s) available for atorvastatin and Carotid Artery Narrowing
| Article | Year |
|---|---|
Pharmacological interventions for asymptomatic carotid stenosis.
Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin | 2023 |
[Secondary prevention after ischemic stroke].
Topics: Administration, Oral; Angioplasty, Balloon; Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Carotid Stenosis; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Smoking Prevention; Stents; Stroke; Vertebral Artery Dissection | 2003 |
Maximizing the cost-effectiveness of lipid-lowering therapy.
Topics: Anticholesteremic Agents; Atorvastatin; Carotid Stenosis; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Pravastatin; Pyrroles; Simvastatin | 1998 |
15 trial(s) available for atorvastatin and Carotid Artery Narrowing
| Article | Year |
|---|---|
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Topics: Aged; Angioplasty, Balloon; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Male; Platelet Aggregation Inhibitors; Pyrroles; Research Design; Stents; Ticlopidine; Treatment Outcome | 2013 |
Influence of carotid artery stenting on cognition of elderly patients with severe stenosis of the internal carotid artery.
Topics: Aged; Analysis of Variance; Angioplasty; Aspirin; Atorvastatin; Carotid Stenosis; China; Clopidogrel; Cognition; Female; Heptanoic Acids; Humans; Male; Pyrroles; Quality of Life; Regional Blood Flow; Stents; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2014 |
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Stenosis; Chemokine CCL2; Cholesterol, LDL; Drug Synergism; Female; Heptanoic Acids; Humans; Hypertension; Macrophages; Male; Middle Aged; NF-kappa B; Pyrroles; RNA, Messenger | 2008 |
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Carotid Arteries; Carotid Stenosis; Contrast Media; Dextrans; Double-Blind Method; Female; Ferrosoferric Oxide; Heptanoic Acids; Humans; Inflammation; Iron; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanoparticles; Oxides; Pyrroles | 2009 |
Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.
Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Artery, Common; Carotid Stenosis; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pyrroles; Tunica Intima; Tunica Media; Ultrasonography | 2009 |
Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
Topics: Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Carotid Stenosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diffusion Magnetic Resonance Imaging; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Rupture; Severity of Illness Index; Time Factors; Treatment Outcome; Triglycerides; Ultrasonography | 2009 |
Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Stenosis; Cerebrovascular Disorders; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography, Doppler | 2010 |
Reduction in arterial wall strain with aggressive lipid-lowering therapy in patients with carotid artery disease.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents; Atorvastatin; Biomechanical Phenomena; Carotid Stenosis; China; Contrast Media; Dextrans; Double-Blind Method; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Magnetic Resonance Angiography; Magnetite Nanoparticles; Male; Middle Aged; Prospective Studies; Pyrroles; Severity of Illness Index; Stress, Mechanical; Time Factors; Treatment Outcome | 2011 |
The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study.
Topics: Aged; Atorvastatin; Carotid Stenosis; Cholesterol, LDL; Densitometry; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Interpretation, Computer-Assisted; Male; Pilot Projects; Pyrroles; Ultrasonography | 2011 |
Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Carotid Artery, Internal; Carotid Stenosis; Cell Adhesion Molecules; Cholesterol; Cholesterol, LDL; Cytokines; Dilatation, Pathologic; Endothelins; Female; Heptanoic Acids; Humans; Interleukin-1; Interleukin-6; Male; Middle Aged; Pyrroles; Radiography; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography; Vascular Cell Adhesion Molecule-1 | 2005 |
3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies.
Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Pressure; Carotid Stenosis; Cohort Studies; Double-Blind Method; Evaluation Studies as Topic; Female; Heptanoic Acids; Humans; Lipids; Male; Middle Aged; Placebos; Pyrroles; Regression Analysis; Research Design; Risk Factors; Time Factors; Ultrasonography | 2005 |
Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.
Topics: Allylamine; Atherosclerosis; Atorvastatin; Carotid Stenosis; Colesevelam Hydrochloride; Double-Blind Method; Female; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipid Metabolism; Magnetic Resonance Imaging; Male; Middle Aged; Niacin; Prospective Studies; Pyrroles | 2007 |
Mapping spatial and temporal changes in carotid atherosclerosis from three-dimensional ultrasound images.
Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Artery, Common; Carotid Stenosis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Pyrroles; Treatment Outcome; Ultrasonography | 2008 |
Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Cholesterol; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Interleukin-18; Interleukin-6; Male; Middle Aged; Pravastatin; Probability; Prospective Studies; Pyrroles; Simvastatin; Triglycerides; Tunica Intima; Ultrasonography | 2008 |
Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
Topics: Aged; Atorvastatin; Biomarkers; Blood Pressure; C-Reactive Protein; Calcinosis; Carotid Stenosis; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2008 |
17 other study(ies) available for atorvastatin and Carotid Artery Narrowing
| Article | Year |
|---|---|
More on carotid atherosclerosis and ezetimibe.
Topics: Atorvastatin; Carotid Artery Diseases; Carotid Stenosis; Coronary Disease; Diabetes Mellitus, Type 2; Ezetimibe; Humans | 2017 |
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.
Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Stenosis; Cohort Studies; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 9; Middle Aged; Neutrophil Activation; Neutrophils; NF-kappa B; Osteopontin; Osteoprotegerin; Pyrimidines; Pyrroles; RANK Ligand; Risk Factors; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2014 |
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Topics: Aged; Atorvastatin; Brain Ischemia; Carotid Stenosis; Cerebral Hemorrhage; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Treatment Outcome | 2008 |
Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?".
Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; Carotid Stenosis; Ferric Compounds; Heptanoic Acids; Humans; Inflammation; Macrophages; Nanoparticles; Pyrroles | 2009 |
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
Topics: Age Distribution; Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Carotid Stenosis; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Heptanoic Acids; Humans; Ischemic Attack, Transient; Outcome Assessment, Health Care; Pyrroles; Stroke; Treatment Outcome | 2009 |
Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass.
Topics: Administration, Oral; Animals; Atorvastatin; Benzopyrans; Calcium Dobesilate; Cardiovascular Agents; Carotid Stenosis; Clopidogrel; Disease Models, Animal; Ethanolamines; Graft Occlusion, Vascular; Heptanoic Acids; Hyperplasia; Jugular Veins; Male; Nebivolol; Pyrroles; Rabbits; Ticlopidine; Tunica Intima; Vascular Surgical Procedures | 2009 |
Three-dimensional carotid ultrasound segmentation variability dependence on signal difference and boundary orientation.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Biometry; Carotid Arteries; Carotid Stenosis; Female; Heptanoic Acids; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Pattern Recognition, Automated; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Surface Properties; Ultrasonography | 2010 |
Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
Topics: Aged; Angioplasty; Atorvastatin; Biomarkers; C-Reactive Protein; Calcinosis; Carotid Stenosis; Combined Modality Therapy; Down-Regulation; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Stents; Time Factors; Treatment Outcome; Ultrasonography, Doppler | 2010 |
Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Anticholesteremic Agents; Arachidonate 5-Lipoxygenase; Atorvastatin; Carotid Stenosis; Carrier Proteins; Disease Models, Animal; Elastic Tissue; Enzyme-Linked Immunosorbent Assay; Gene Expression; Heptanoic Acids; Leukotriene D4; Lipids; Lipoxins; Membrane Proteins; Muscle, Smooth, Vascular; Pyrroles; Rabbits; Receptors, Leukotriene; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tunica Intima | 2010 |
Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.
Topics: Aged; Aged, 80 and over; Angioplasty; Atorvastatin; Biomarkers; Carotid Stenosis; Cross-Sectional Studies; Down-Regulation; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipoproteins, LDL; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed | 2010 |
Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a).
Topics: Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Blood Coagulation Tests; Carotid Stenosis; Clopidogrel; Colitis, Ulcerative; Female; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Lipoprotein(a); Magnetic Resonance Imaging; Middle Aged; Pyrroles; Risk Factors; Stroke; Thrombosis; Ticlopidine; Ultrasonography | 2011 |
Bilateral carotid atherosclerosis: an inevitable consequence of homozygous familial hypercholesterolemia.
Topics: Angioplasty; Atorvastatin; Carotid Stenosis; Disease Progression; Genetic Predisposition to Disease; Heptanoic Acids; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Liver Transplantation; Phenotype; Pyrroles; Radiography; Severity of Illness Index; Stents; Time Factors; Treatment Outcome; Treatment Refusal | 2011 |
Right hemiparesis in right carotid stenosis.
Topics: Aged; Anticholesteremic Agents; Atherectomy; Atorvastatin; Carotid Stenosis; Clopidogrel; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Heptanoic Acids; Humans; Male; Paresis; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Treatment Outcome; Ultrasonography | 2011 |
Asymptomatic carotid stenosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Aspirin; Asymptomatic Diseases; Atorvastatin; Azetidines; Carotid Stenosis; Diet, Mediterranean; Drug Therapy, Combination; Exercise Therapy; Ezetimibe; Female; Heptanoic Acids; Humans; Perindopril; Pyrroles; Risk; Stroke; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2013 |
Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
Topics: Aspirin; Atorvastatin; Carotid Stenosis; Coronary Artery Disease; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pyrroles; Radiography | 2006 |
Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells.
Topics: Animals; Apoptosis; Atorvastatin; Carotid Stenosis; Cell Division; Cells, Cultured; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Muscle, Smooth, Vascular; Pravastatin; Pyrroles; Rabbits; Simvastatin | 1997 |
Systemic cause of unstable atherosclerotic plaques. Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque (ATROCAP) study group.
Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Carotid Stenosis; Cause of Death; Heptanoic Acids; Humans; Pyrroles; Risk Factors | 2000 |